Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation

D I Bulas1, A Jones, J J Seibert

  • 1Department of Radiology and Diagnostic Imaging, Children's National Medical Center, Washington, DC 20010, USA. dbulas@cnmc.org

Pediatric Radiology
|December 2, 2000
PubMed

Insights

Transcranical Doppler imaging (TCDI) shows lower velocities than transcranial Doppler (TCD) in children with sickle cell disease. These differences impact stroke risk assessment and prophylactic transfusion decisions based on the STOP protocol.

Area of Science:

  • Neurology
  • Pediatrics
  • Medical Imaging

Background:

  • Sickle cell anemia poses a high stroke risk in children.
  • The Stroke Prevention Trial in Sickle Cell Anemia (STOP) protocol uses transcranial Doppler (TCD) to identify high-risk individuals based on specific velocity thresholds.
  • Concerns exist regarding the comparability of TCD measurements obtained with different ultrasound devices and techniques.

Purpose of the Study:

  • To compare findings between nonimaging TCD and transcranial duplex imaging (TCDI) in children with sickle cell disease.
  • To evaluate the consistency of stroke risk assessment using these two ultrasound modalities.

Main Methods:

  • Twenty-two children with sickle cell disease underwent both TCD and TCDI examinations on the same day.
  • Examinations were conducted independently, with manual measurements recorded for both techniques.
  • Comparisons were made for mean, peak systolic, and end-diastolic velocities, including a subgroup analysis of manual versus electronic measurements.

Main Results:

  • Transcranial Doppler imaging (TCDI) consistently yielded lower velocity measurements across all evaluated intracranial arteries compared to TCD.
  • Time-averaged maximum mean velocity (TAMMV) differences were smallest in the middle cerebral artery (-9.0%) and distal internal carotid artery (-10.8%).
  • Despite velocity differences, risk stratification based on middle cerebral artery TAMMV remained consistent between TCD and TCDI.

Conclusions:

  • Velocity measurements obtained via TCDI tend to be lower than those from TCD.
  • These discrepancies necessitate careful consideration during stroke risk screening and selection for prophylactic transfusions in sickle cell disease patients.
  • The findings highlight the importance of understanding modality-specific differences for accurate application of the STOP protocol.
Abstract